Cellectar Biosciences, Inc. (CLRB) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 10, 2026 filed July 8, 2026 | Loren Stefan Insider | $0 | 15,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed July 7, 2026 | Kolean Chad J CFO | $0 | 92,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed July 7, 2026 | DRISCOLL FREDERICK W Director | $0 | 25,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed July 7, 2026 | Chanan-Khan Asher Director | $0 | 25,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed July 7, 2026 | CARUSO JAMES V President & CEO | $0 | 250,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free